[go: up one dir, main page]

NO20054124L - Dyre-fri celle kultur metode - Google Patents

Dyre-fri celle kultur metode

Info

Publication number
NO20054124L
NO20054124L NO20054124A NO20054124A NO20054124L NO 20054124 L NO20054124 L NO 20054124L NO 20054124 A NO20054124 A NO 20054124A NO 20054124 A NO20054124 A NO 20054124A NO 20054124 L NO20054124 L NO 20054124L
Authority
NO
Norway
Prior art keywords
cell culture
animal
relates
animal origin
culture method
Prior art date
Application number
NO20054124A
Other languages
English (en)
Other versions
NO20054124D0 (no
Inventor
Brigitte Ghislaine Lousi Aerts
Yves Jules Maurice Ghislain
Marie-Monique Jane Gonze
Isabelle Solange Lucie Knott
Carine Maggetto
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20054124D0 publication Critical patent/NO20054124D0/no
Publication of NO20054124L publication Critical patent/NO20054124L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Foreliggende oppfinnelse angår en fremgangsmåte for å få animalsk, foretrukket human, diploid forankringsavhengig cellekultur, i fravær av eksogene komponenter av primær animalsk opprinnelse og et celledyrkningsmedium hovedsakelig fritt for eksogene komponenter av primær animalsk opprinnelse egnet for å utføre nevnte fremgangsmåte. Spesielt angår oppfinnelsen et celledyrkningsmedium som omfatter minst én, mer foretrukket mange, eksogene vekstfaktorer av ikke-animalsk opprinnelse. Foreliggende oppfinnelse angår også en fremgangsmåte for dyrking av animalske, foretrukket humane diploide forankringsavhengige celler i et medium ifølge oppfinnelsen, som omfatter anvendelse av et trypsin-substitutt av ikke-animalsk opprinnelse for passasje av celler. Oppfinnelsen angår videre en fremgangsmåte for å fremstille virus, virale vaksiner og lignende.
NO20054124A 2003-03-03 2005-09-05 Dyre-fri celle kultur metode NO20054124L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0304799.0A GB0304799D0 (en) 2003-03-03 2003-03-03 Novel method
PCT/EP2004/002067 WO2004078955A1 (en) 2003-03-03 2004-03-01 Animal-free cell culture method

Publications (2)

Publication Number Publication Date
NO20054124D0 NO20054124D0 (no) 2005-09-05
NO20054124L true NO20054124L (no) 2005-09-27

Family

ID=9953995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054124A NO20054124L (no) 2003-03-03 2005-09-05 Dyre-fri celle kultur metode

Country Status (17)

Country Link
US (1) US8034617B2 (no)
EP (3) EP2192175A1 (no)
JP (2) JP4787739B2 (no)
KR (1) KR101242090B1 (no)
CN (2) CN101200705A (no)
AU (1) AU2004217807B2 (no)
BR (1) BRPI0407636A (no)
CA (1) CA2517327A1 (no)
CO (1) CO5601047A2 (no)
GB (1) GB0304799D0 (no)
IS (1) IS7992A (no)
MA (1) MA27631A1 (no)
MX (1) MXPA05009096A (no)
NO (1) NO20054124L (no)
NZ (1) NZ541908A (no)
RU (1) RU2369634C2 (no)
WO (1) WO2004078955A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2403357T3 (es) 2003-12-11 2013-05-17 Isto Technologies Inc. Sistema de cartílago particulado
JP4650798B2 (ja) * 2004-04-19 2011-03-16 デンカ生研株式会社 ウイルスの生産方法
JP2008518597A (ja) * 2004-10-29 2008-06-05 セントカー・インコーポレーテツド 化学的規定培地組成物
EP1862537B1 (en) * 2005-03-10 2013-05-08 Kyoritsu Seiyaku Corporation Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine
EP1891207A2 (en) * 2005-06-03 2008-02-27 Biovitrum AB Process for cultivating animal cells comprising the feeding of plant-derived peptones
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
EP1764117A1 (en) 2005-09-20 2007-03-21 Zimmer GmbH Implant for the repair of a cartilage defect and method for manufacturing the implant
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
WO2008128075A1 (en) 2007-04-12 2008-10-23 Isto Technologies, Inc. Compositions and methods for tissue repair
FI20075417A0 (fi) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
DK2250251T3 (en) 2008-01-09 2018-01-22 Sartorius Stedim Cellca Gmbh Improved culture medium additive and method of using it
SG2014014385A (en) 2009-02-17 2014-04-28 Glaxosmithkline Biolog Sa Inactivated dengue virus vaccine with aluminium-free adjuvant
PT2563904E (pt) * 2010-04-26 2015-05-12 Novartis Ag Meio de cultura de células aperfeiçoado
CN101831415B (zh) * 2010-05-12 2012-05-30 江苏博立生物制品有限公司 一种提高糖化酶发酵水平的方法
DK2681306T3 (en) * 2011-02-28 2019-04-23 Harvard College CELL CULTURE SYSTEM
ES2587876T3 (es) 2011-12-08 2016-10-27 Yeda Research And Development Co. Ltd. Células pulmonares fetales de mamífero y uso terapéutico de las mismas
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
US20130281355A1 (en) * 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
JP6041199B2 (ja) * 2012-09-14 2016-12-07 国立大学法人大阪大学 三次元細胞培養体の製造方法
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
WO2016203477A1 (en) 2015-06-18 2016-12-22 Yeda Research And Development Co. Ltd. Conditioning protocols and use of same for tissue regeneration
US10004795B2 (en) * 2015-09-08 2018-06-26 Fundacao Butantan Process for preparing an attenuated tetravalent dengue vaccine
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
CN105567628B (zh) * 2016-01-30 2019-07-12 令世鑫 一种全悬浮培养mdck细胞的低血清培养基
CN105779376B (zh) * 2016-03-24 2019-08-30 友康恒业生物科技（北京）有限公司 一种流感病毒分离无血清培养基及其用途和制备
CN105695393B (zh) * 2016-03-24 2019-09-10 友康恒业生物科技（北京）有限公司 一种mdck细胞无血清培养基及其用途和制备
KR101925079B1 (ko) * 2017-05-24 2018-12-04 가천대학교 산학협력단 Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법
CN107432931B (zh) * 2017-08-03 2018-04-13 长春祈健生物制品有限公司 一种微载体培养水痘病毒制备疫苗的方法
CN119265099A (zh) * 2019-01-17 2025-01-07 勃林格殷格翰动物保健有限公司 用于禽类疫苗生产的无血清培养基及其用途
WO2021138482A1 (en) 2019-12-31 2021-07-08 Air Protein, Inc. High protein food compositions
JP2023511430A (ja) * 2020-01-24 2023-03-17 エア プロテイン，インコーポレイテッド 微生物由来蛋白質加水分解物、ならびにその調製法およびその用途
CN113373107B (zh) * 2021-01-29 2022-12-30 上海生物制品研究所有限责任公司 一种大规模制备传代鸡胚细胞生产病毒的方法
WO2024039216A1 (ko) * 2022-08-19 2024-02-22 셀미트주식회사 동물세포 또는 동물 세포주의 배양방법
CN115627255B (zh) * 2022-12-01 2023-04-07 天信和(苏州)生物科技有限公司 一种采用低血清培养基培养人二倍体细胞的方法
CN119979445B (zh) * 2025-04-10 2025-09-09 四川大学 一种培养基、口腔黏膜上皮细胞模型，及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2018228C (en) * 1989-06-05 1996-02-27 Nancy L. Parenteau Cell culture systems and media
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4115722A1 (de) 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
RU2057176C1 (ru) * 1992-05-20 1996-03-27 Институт генетики АН Республики Молдова Питательная среда для культивирования клеток человека и животных
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
NZ256278A (en) 1992-09-18 1996-11-26 Smithkline Beecham Biolog Live attenuated hepatitis a virus adapted to grow in mrc-5 cells
CN1088984A (zh) * 1993-11-11 1994-07-06 江西省医学科学研究所 一种用于造血祖细胞培养的无血清培养基
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
ATE542891T1 (de) 1994-11-10 2012-02-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freier kultur
WO1998000521A1 (fr) * 1996-06-28 1998-01-08 The Green Cross Corporation Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives
AU3813597A (en) 1996-07-26 1998-02-20 University Of Manitoba Serum-free medium for growth of anchorage-dependant mammalian cells
ATE399855T1 (de) * 1996-10-10 2008-07-15 Invitrogen Corp Tierzellkulturmedium mit pflanzlichen nährstoffen
AU7984498A (en) 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2775983B1 (fr) 1998-03-13 2000-11-10 Pasteur Merieux Serums Vacc Milieu et procede de propagation et de multiplication virales
WO1999057246A1 (en) * 1998-05-01 1999-11-11 Life Technologies, Inc. Animal cell culture media comprising non-animal or plant-derived nutrients
US6406909B1 (en) * 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
US6623959B2 (en) * 2001-06-13 2003-09-23 Ethicon, Inc. Devices and methods for cell harvesting

Also Published As

Publication number Publication date
AU2004217807A1 (en) 2004-09-16
GB0304799D0 (en) 2003-04-09
IS7992A (is) 2005-08-18
RU2369634C2 (ru) 2009-10-10
EP2186885A1 (en) 2010-05-19
KR101242090B1 (ko) 2013-03-08
WO2004078955A1 (en) 2004-09-16
JP4787739B2 (ja) 2011-10-05
EP1599580A1 (en) 2005-11-30
JP2006519023A (ja) 2006-08-24
CO5601047A2 (es) 2006-01-31
EP2192175A1 (en) 2010-06-02
NZ541908A (en) 2008-04-30
JP2010273683A (ja) 2010-12-09
CN101200705A (zh) 2008-06-18
CN1756837A (zh) 2006-04-05
US20060183224A1 (en) 2006-08-17
NO20054124D0 (no) 2005-09-05
MA27631A1 (fr) 2005-11-01
CN1756837B (zh) 2010-05-26
US8034617B2 (en) 2011-10-11
CA2517327A1 (en) 2004-09-16
RU2005125606A (ru) 2006-03-10
MXPA05009096A (es) 2005-10-19
AU2004217807B2 (en) 2009-06-25
BRPI0407636A (pt) 2006-02-21
KR20050105509A (ko) 2005-11-04

Similar Documents

Publication Publication Date Title
NO20054124L (no) Dyre-fri celle kultur metode
MX2007005132A (es) Medios libres de proteina animal para cultivo de celulas.
ES2526191T3 (es) Método para producir virus influenza B infeccioso en cultivo celular
ATE469972T1 (de) Multiplasmid-system zur erzeugung des grippevirus
BR0313559A (pt) Método para o cultivo de células primárias e para a amplificação de vìrus sob condições isentas de soro
MX2009006469A (es) Metodo de duplicacion del virus de la influenza en cultivo.
RU2008106445A (ru) Вирусоподобные корпускулы (частицы) в качестве противопарамиксовирусной вакцины
FR08C0046I1 (fr) Reconstitution in vitro de virus a arn de polarite negative segmentes
MX2009002741A (es) Lineas de celulas mdck que soportan el crecimiento viral para altos titulos y proceso de biorreactor que utiliza las mismas.
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
DK1201749T3 (da) Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter
AR079710A1 (es) Proceso para el cultivo de celulas adherentes
AR069885A1 (es) Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional
Mabrouk et al. Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine)
WO2005115448A3 (en) Multi plasmid system for the production of influenza virus
UA100849C2 (ru) Способ репликации вируса гриппа в культуре
DK1334197T3 (da) Gær-afledt vaccine mod IPNV
AR069884A1 (es) Metodos para empacar vectores de virus de estomatitis vesicular de propagacion defectuosa
TW200732475A (en) Pulmonary stem cells, related methods and kits
EP1517987A4 (en) PULMONARY CELLS OF THE RAT DES COTONNIERS FOR VIRUS CULTURE
ATE464375T1 (de) Verfahren zur herstellung von virusmaterial
EP1739167A4 (en) PROCESS FOR VIRUS PRODUCTION
DE602004029789D1 (de) Keratinozyten-kulturverfahren und verwendung davon
RU2009144970A (ru) Двухстадийный температурный профиль культивирования вирусов
UA6132U (en) Liquid cultural inactivated vaccine against aueski disease in pigs, sheep, and fur-bearing animals

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application